Dear Valued Partner, As of March 6th, we have officially stopped compounding Tirzepatide in response to the latest FDA announcement. While we were dispensing the limited inventory we had on hand, the overwhelming influx of orders resulted in that supply being depleted much faster than anticipated. Tirzepatide is completely out of stock. Unfortunately all pending orders will be canceled. We continue to hear from practices across the country that patients are still unable to access the commercial product. As members of the Alliance for Pharmacy Compounding (APC), we remain hopeful that our collective voices will be heard and that a path forward will allow compounding pharmacies to continue supporting patients in need. Any changes or opportunities to reintroduce this product will be communicated promptly. Thank you for your continued trust. Hallandale Pharmacy |